ArticleNucleic acids research2026
Alexidine, identified as a Z-DNA inducer by the NanoZ screening platform, acts as a transcriptional regulator.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Z-DNA is a left-handed DNA helix implicated in gene regulation, genome stability, and immune responses, yet effective small-molecule modulators in cells remain scarce. To address this gap, we developed NanoZ, a two-step screening platform designed to identify Z-DNA-inducing molecules. The first step, a DNA condensation assay, detects ligand-induced DNA condensation using gold nanoparticles functionalized with Z-DNA-forming sequences, providing a rapid optical readout through localized surface plasmon resonance. The second step, a biophysical validation pipeline, employs circular dichroism, 2-aminopurine fluorescence, and NMR spectroscopy to confirm Z-DNA formation. Using this workflow, we screened 2000 compounds from the Natural Product and Prestwick Chemical Libraries, identifying 18 positive hits in the condensation assay and selecting Alexidine dihydrochloride as a Z-DNA inducer. Alexidine efficiently promoted the B-to-Z transition and DNA condensation in vitro, and markedly increased Z-DNA formation in cells, as confirmed by immunofluorescence and ChIP-seq. Genome-wide analysis revealed that Alexidine-induced Z-DNA localized to transcriptionally active, purine-pyrimidine repeat-rich loci, leading to gene repression. Molecular dynamics simulations showed that Alexidine bridges adjacent Z-DNA helices, facilitating condensation. Collectively, our findings highlight Alexidine as the first small-molecule Z-DNA inducer that modulates transcription in cells and establish NanoZ as a versatile platform for discovering Z-DNA modulators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.